Oligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps

Antiviral Research

Volumn 109, Issue 1, 2014, Pages 83-96

  Sauter, Monica M ^a   Gauger, Joshua J L ^b   Brandt, Curtis R ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

ARPE 19; Herpes simplex virus; ICP4; NF B; Retinal pigment epithelium; TLR9

Indexed keywords

GUANOSINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGONUCLEOTIDE; TOLL LIKE RECEPTOR 9; ANTIVIRUS AGENT; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; GENE PRODUCT; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS TYPE 1 INFECTION; HUMAN; HUMAN ADHERENT RETINAL PIGMENTED EPITHELIAL CELL; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; PRIORITY JOURNAL; RETINA CELL; VERO CELL LINE; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS REPLICATION; WESTERN BLOTTING; ANIMAL; CHLOROCEBUS AETHIOPS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; GENE EXPRESSION REGULATION, VIRAL; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; NF-KAPPA B; OLIGONUCLEOTIDES; TOLL-LIKE RECEPTOR 9; VERO CELLS; VIRAL PROTEINS; VIRUS ATTACHMENT;

EID: 84904564936     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.06.015     Document Type: Article

References (70)

1. S. Akira, and K. Takeda Toll-like receptor signalling Nat. Rev. Immunol. 4 2004 499 511 (Pubitemid 38931765)
2. C. Amici, A. Rossi, A. Costanzo, S. Ciafre, B. Marinari, M. Balsamo, M. Levrero, and M.G. Santoro Herpes simplex virus disrupts NF-kappaB regulation by blocking its recruitment on the IkappaBalpha promoter and directing the factor on viral genes J. Biol. Chem. 281 2006 7110 7117 (Pubitemid 43847475)
3. E.M. Anderson, P. Miller, D. Ilsley, W. Marshall, A. Khvorova, C.A. Stein, and L. Benimetskaya Gene profiling study of G3139- and Bcl-2-targeting siRNAs identifies a unique G3139 molecular signature Cancer Gene Ther. 13 2006 406 414
4. M. Aubert, and J. Blaho The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells J. Virol. 73 1999 2803 2813 (Pubitemid 29135667)
5. F.J. Barrat, and R.L. Coffman Development of TLR inhibitors for the treatment of autoimmune diseases Immunol. Rev. 223 2008 271 283 (Pubitemid 351986175)
6. D.I. Bernstein, N. Goyette, R. Cardin, E.R. Kern, G. Boivin, J. Ireland, J.M. Juteau, and A. Vaillant Amphipathic DNA polymers exhibit antiherpetic activity in vitro and in vivo Antimicrob. Agents Chemother. 52 2008 2727 2733
7. N. Boivin, R. Menasria, J. Piret, and G. Boivin Modulation of TLR9 response in a mouse model of herpes simplex virus encephalitis Antiviral Res. 96 2012 414 421
8. W.C. Brown, D.M. Estes, S.E. Chantler, K.A. Kegerreis, and C.E. Suarez DNA and a CpG oligonucleotide derived from Babesia bovis are mitogenic for bovine B cells Infect. Immun. 66 1998 5423 5432 (Pubitemid 29044640)
9. M. Cai, M. Li, K. Wang, S. Wang, Q. Lu, J. Yan, K.L. Mossman, R. Lin, and C. Zheng The herpes simplex virus 1-encoded envelope glycoprotein B activates NF-κB through the Toll-like receptor 2 and MyD88/TRAF6-dependent signaling pathway PLoS One 8 2013 e54586
10. S. Cai, and C.R. Brandt Induction of interleukin-6 in human retinal epithelial cells by an attenuated Herpes simplex virus vector requires viral replication and NFkappaB activation Exp. Eye Res. 86 2008 178 188 (Pubitemid 351231882)
11. R.D. Cardin, F.J. Bravo, A.P. Sewell, J. Cummins, L. Flamand, J.M. Juteau, D.I. Bernstein, and A. Vaillant Amphipathic DNA polymers exhibit antiviral activity against systemic murine Cytomegalovirus infection Virol. J. 6 2009 214
12. T.C. Cheung, M.W. Steinberg, L.M. Oborne, M.G. Macauley, S. Fukuyama, H. Sanjo, C. D'Souza, P.S. Norris, K. Pfeffer, K.M. Murphy, K.M. Kronenberg, P.G. Spear, and C.F. Ware Unconventional ligand activation of herpesvirus entry mediator signals cell survival Proc. Natl. Acad. Sci. U. S. A. 106 2009 6244 6249
13. N.A. Counihan, and B.D. Lindenbach Gumming up the works: DNA polymers as HCV entry inhibitors Gastroenterology 137 2009 427 430
14. R. Duan, R.D. de Vries, A.D.M.E. Osterhaus, L. Rameijer, and G.M.G.M. Verjans Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis J. Infect. Dis. 198 2008 659 663
15. R.J. Eisenberg, D. Atanasiu, T.M. Cairns, J.R. Gallagher, C. Krummenacher, and G.H. Cohen Herpes virus fusion and entry: a story with many characters Viruses 4 2012 800 832
16. M. Fatahzadeh, and R.A. Schwartz Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management J. Am. Acad. Dermatol. 57 2007 737 763 (Pubitemid 47553079)
17. S.M. Fennewald, S. Mustain, J. Ojwang, and R.F. Rando Inhibition of herpes simplex virus in culture by oligonucleotides composed entirely of deoxyguanosine and thymidine Antiviral Res. 26 1995 37 54
18. U. Galderisi, A. Cascino, and A. Giordano Antisense oligonucleotides as therapeutic agents J. Cell. Physiol. 181 1999 251 257 (Pubitemid 29463640)
19. W.Y. Gao, R.N. Hanes, M.A. Vazquez-Padua, C.A. Stein, J.S. Cohen, and Y.C. Cheng Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides Antimicrob. Agents Chemother. 34 1990 808 812 (Pubitemid 20142403)
20. B.T. Gjertsen, T. Bredholt, N. Anensen, and O.K. Vintermyr Bcl-2 antisense in the treatment of human malignancies: a delusion in targeted therapy Curr. Pharm. Biotechnol. 8 2007 373 381 (Pubitemid 350268196)
21. M.L. Goodkin, A.T. Ting, and J.A. Blaho NF-kappaB is required for apoptosis prevention during herpes simplex virus type 1 infection J. Virol. 77 2003 7261 7280 (Pubitemid 36734495)
22. D.R. Grau, R.J. Visalli, and C.R. Brandt Herpes simplex virus stromal keratitis is not titer-dependent and does not correlate with neurovirulence Invest. Ophthalmol. Vis. Sci. 30 1989 2474 2480 (Pubitemid 20021787)
23. D. Gregory, D. Hargett, D. Holmes, E. Money, and S.L. Bachenheimer Efficient replication by herpes simplex virus type 1 involves activation of the IkappaB kinase-IkappaB-p65 pathway J. Virol. 78 2004 13582 13590 (Pubitemid 39612758)
24. E.M. Guzman, N. Cheshenko, V. Shende, M.J. Keller, N. Goyette, J.M. Juteau, G. Boivin, A. Vaillant, and B.C. Herold Amphipathic DNA polymers are candidate vaginal microbicides and block herpes simplex virus binding, entry and viral gene expression Antivir. Ther. 12 2007 1147 1156
25. P.H. Hagedorn, V. Yakimov, S. Ottosen, S. Kammler, N.F. Nielsen, A.M. Høg, M. Hedtjärn, M. Meldgaard, M.R. Møller, H. Orum, T. Koch, and M. Lindow Hepatotoxic potential of therapeutic oligonucleotides can be predicted from their sequence and modification pattern Nucleic Acid Ther. 23 2013 302 310
26. D. Hargett, S. Rice, and S.L. Bachenheimer Herpes simplex virus type 1 ICP27-dependent activation of NF-kappaB J. Virol. 80 2006 10565 10578 (Pubitemid 44628903)
27. K. Hayashi, L.C. Hooper, M.S. Chin, C.N. Nagineni, B. Detrick, and J.J. Hooks Herpes simplex virus 1 (HSV-1) DNA and immune complex (HSV-1-human IgG) elicit vigorous interleukin 6 release from infected corneal cells via Toll-like receptors J. Gen. Virol. 87 2006 2161 2169 (Pubitemid 44178094)
28. K.A. Horan, K. Hansen, M.R. Jakobsen, C.K. Holm, S. Søby, L. Unterholzner, M. Thompson, J.A. West, M.B. Iversen, S.B. Rasmussen, S. Ellermann-Eriksen, E. Kurt-Jones, S. Landolfo, B. Damania, J. Melchjorsen, A.G. Bowie, K.A. Fitzgerald, and S.R. Paludan Proteasomal degradation of herpes simplex virus capsids in macrophages releases DNA to the cytosol for recognition by DNA sensors J. Immunol. 190 2013 2311 2319
29. X. Huang, and Y. Yang Innate immune recognition of viruses and viral vectors Hum. Gene Ther. 20 2009 293 301
30. J.L. Imler, and L. Zheng Biology of Toll receptors: lessons from insects and mammals J. Leukoc. Biol. 75 2004 18 26 (Pubitemid 38166775)
31. H.L. Janssen, H.W. Reesink, E.J. Lawitz, S. Zeuzem, M. Rodriguez-Torres, K. Patel, A.J. van der Meer, K.A.K. Patic, A. Chen, Y. Zhou, R. Persson, B.D. King, S. Kauppinen, A.A. Levin, and M.R. Hodges Treatment of HCV infection by targeting microRNA New Engl. J. Med. 368 2013 1685 1694
32. T. Kawai, and S. Akira Innate immune recognition of viral infection Nat. Immunol. 7 2006 131 137 (Pubitemid 43135878)
33. T. Kim, S. Pazhoor, M. Bao, Z. Zhang, S. Hanabuchi, V. Facchinetti, L. Bover, J. Plumas, L. Chaperot, J. Qin, and Y.-J. Liu Aspartate-glutamate- alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells Proc. Natl. Acad. Sci. U. S. A. 107 2010 15181 15186
34. A.M. Krieg, A.K. Yi, S. Matson, T.J. Waldschmidt, G.A. Bishop, R. Teasdale, G.A. Koretzky, and D.M. Klinman CpG motifs in bacterial DNA trigger direct B-cell activation Nature 374 1995 546 549
35. A. Krug, G.D. Luker, W. Barchet, D.A. Leib, S. Akira, and M. Colonna Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9 Blood 103 2004 1433 1437 (Pubitemid 38168659)
36. M.V. Kumar, C.N. Nagineni, M.S. Chin, J.J. Hooks, and B. Detrick Innate immunity in the retina: Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells J. Neuroimmunol. 153 2004 7 15 (Pubitemid 38950922)
37. E.A. Kurt-Jones, M. Chan, S. Zhou, J. Wang, G. Reed, R. Bronson, M.M. Arnold, D.M. Knipe, and R.W. Finberg Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis Proc. Natl. Acad. Sci. U. S. A. 101 2004 1315 1320 (Pubitemid 38182686)
38. E. Latz, A. Verma, A. Visintin, M. Gong, C.M. Sirois, D.C.G. Klein, B.G. Monks, C.J. McKnight, M.S. Lamphier, W.P. Duprex, T. Espevik, and D.T. Golenbock Ligand-induced conformational changes allosterically activate Toll-like receptor 9 Nat. Immunol. 8 2007 772 779 (Pubitemid 46965353)
39. A.M. Lee, J.M. Rojek, A. Gundersen, U. Ströher, J.M. Juteau, A. Vaillant, and S. Kunz Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers Virology 372 2008 107 117 (Pubitemid 351215460)
40. V. Leoni, T. Gianni, S. Salvioli, and G. Campadelli-Fiume Herpes simplex virus glycoproteins gH/gL and gB bind Toll-like receptor 2, and soluble gH/gL is sufficient to activate NF-κB J. Virol. 86 2012 6555 6562
41. X.Q. Liu, K. Fitzgerald, E. Kurt-Jones, R. Fingerg, and D.M. Knipe Herpesvirus tegument protein activates NF-kB signaling through the TRAF6 adaptor protein Proc. Natl. Acad. Sci. U. S. A. 105 2008 11335 11339
42. A. Luganini, F. Caposio, S. Landolfo, and G. Gribaudo Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry Antimicrob. Agents Chemother. 52 2008 1111 1120 (Pubitemid 351358395)
43. J. Lund, A. Sato, S. Akira, R. Medzhitov, and A. Iwasaki Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells J. Exp. Med. 198 2003 513 520 (Pubitemid 36976063)
44. N. Martinez-Martin, and A. Viejo-Borbolla Toll-like receptor-mediated recognition of herpes simplex virus Front. Biosci. (Schol Ed) S2 2010 718 729
45. M.A. Medici, M.T. Sciortino, D. Perri, C. Amici, E. Avitabile, M. Ciotti, E. Balestrieri, E. De Smaele, G. Franzoso, and A. Mastino Protection by herpes simplex virus glycoprotein D against Fas-mediated apoptosis: role of nuclear factor kappaB J. Biol. Chem. 278 2003 36059 36067 (Pubitemid 37139926)
46. A. Mescalchin, and T. Restle Oligomeric nucleic acids as antivirals Molecules 16 2011 1271 1296
47. F. Noordeen, A. Vaillant, and A.R. Jilbert Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro Antimicrob. Agents Chemother. 57 2013 5291 5298
48. F. Noordeen, A. Vaillant, and A.R. Jilbert Nucleic acid polymers prevent the establishment of duck hepatitis B virus infection in vivo Antimicrob. Agents Chemother. 57 2013 5299 5306
49. M. Peter, K. Bode, G.B. Lipford, F. Eberle, K. Heeg, and A.H. Dalpke Characterization of suppressive oligodeoxynucleotides that inhibit Toll-like receptor-9-mediated activation of innate immunity Immunology 123 2007 118 128 (Pubitemid 350256002)
50. S.B. Rasmussen, L.N. Sørensen, L. Malmgaard, N. Ank, J.D. Baines, Z.J. Chen, and S.R. Paludan Type I interferon production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems J. Virol. 81 2007 13315 13324 (Pubitemid 350247828)
51. V.A.K. Rathinam, and K.A. Fitzgerald Cytosolic surveillance and antiviral immunity Curr. Opin. Virol. 1 2011 455 462
52. K.L. Roberts, and J.D. Baines UL31 of Herpes simplex virus 1 is necessary for optimal NF-{kappa}B activation and expression of viral gene products J. Virol. 85 2011 4947 4953
53. M.T. Sciortino, M.A. Medici, F. Marino-Merlo, D. Zaccaria, M. Giuffrè-Cuculletto, A. Venuti, S. Grelli, and A. Mastino Involvement of HVEM receptor in activation of nuclear factor kappaB by herpes simplex virus 1 glycoprotein D Cell. Microbiol. 10 2008 2297 2311
54. M.T. Sciortino, M.A. Medici, F. Marino-Merlo, D. Zaccaria, M. Giuffrè-Cuculletto, A. Venuti, S. Grelli, P. Bramanti, and A. Mastino Involvement of gD/HVEM interaction in NF-kB-dependent inhibition of apoptosis by HSV-1 gD Biochem. Pharmacol. 76 2008 1522 1532
55. B. Shogan, L. Kruse, G.B. Mulamba, A. Hu, and D.M. Coen Virucidal activity of a GT-rich oligonucleotide against herpes simplex virus mediated by glycoprotein B J. Virol. 80 2006 4740 4747
56. J.W. Streilein, M.R. Dana, and B.R. Ksander Immunity causing blindness: five different paths to herpes stromal keratitis Immunol. Today 18 1997 443 449 (Pubitemid 27381987)
57. S. Sun, C. Beard, R. Jaenisch, P. Jones, and J. Sprent Mitogenicity of DNA from different organisms for murine B cells J. Immunol. 159 1997 3119 3125 (Pubitemid 127482068)
58. A. Takaoka, Z. Wang, M.K. Choi, I.H. Yana, H. Negishi, T. Ban, Y. Lu, M. Miyagishi, T. Kodama, K. Honda, Y. Ohba, and T. Taniguchi DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response Nature 448 2007 501 505 (Pubitemid 47123520)
59. S. Takeda, D. Miyazaki, S.-I. Sasaki, Y. Yamamoto, Y. Terasaka, K. Yakura, S. Yamagami, N. Ebihara, and Y. Inoue Roles played by toll-like receptor-9 in corneal endothelial cells after herpes simplex virus type 1 infection Invest. Ophthalmol. Vis. Sci. 52 2011 6729 6736
60. L. Unterholzner, S.E. Keating, M. Baran, K.A. Horan, S.B. Jensen, S. Sharma, C.M. Sirois, T. Jin, E. Latz, T.S. Xiao, K.A. Fitzgerald, S.R. Paludan, and A.G. Bowie IFI16 is an innate immune sensor for intracellular DNA Nat. Immunol. 11 2010 997 1004
61. A. Vaillant, J. Juteau, H. Lu, S. Liu, C. Lackman-Smith, R. Ptak, and S. Jiang Phosphorothioate oligonucleotides inhibit human immunodeficiency virus type 1 fusion by blocking gp41 core formation Antimicrob. Agents Chemother. 50 2006 1393 1401
62. M. van Velzen, T. Missotten, F.B. van Loenen, R.J. Meesters, T.M. Luider, G.S. Baarsma, A.D. Osterhaus, and G.M. Verjans Acyclovir-resistant herpes simplex virus type 1 in intra-ocular fluid samples of herpetic uveitis patients J. Clin. Virol. 57 2013 215 221
63. R.J. Visalli, and C.R. Brandt The HSV-1 UL45 18 kDa gene product is a true late protein and a component of the virion Virus Res. 29 1993 167 178 (Pubitemid 23235071)
64. R.J. Whitley Herpes simplex viruses B.N. Fields, D.M. Knipe, P.M. Howley, Fields Virology vol. 2 1996 Lippincott-Raven Philadelphia 2297 2342
65. J. Winkler, M. Stessl, J. Amartey, and C.R. Noe Off-target effects related to the phosphorothioate modification of nucleic acids ChemMedChem 5 2010 1344 1352
66. J.P. Wong, M.E. Christopher, R.A.M. Salaza, L.Q. Sun, S. Viswanathan, M. Wang, E.G. Saravolac, and M.J. Cairns Broad-spectrum and virus-specific nucleic acid-based antivirals against influenza Front. Biosci. (Schol Ed) 2 2010 791 800
67. J.P. Wong, M.E. Christopher, A.M. Salazar, R.M. Dale, L.Q. Sun, and M. Wang Nucleic acid-based antiviral drugs against seasonal and avian influenza viruses Vaccine Res. 25 2007 3175 3178 (Pubitemid 46482750)
68. G.-Q. Yao, S. Grill, W. Egan, and Y.-C. Gheng Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification Antimicrob. Agents Chemother. 37 1993 1420 1425 (Pubitemid 23202365)
69. S.Y. Zhang, E. Jouanguy, S. Ugolini, A. Smahi, G. Elain, P. Romero, D. Segal, V. Sancho-Shimizu, L. Lorenzo, A. Puel, C. Picard, A. Chapgier, S. Plancoulaine, M. Titeux, C. Cognet, H. von Bernuth, C.L. Ku, A. Casrouge, X.X. Zhang, L. Barreiro, J. Leonard, C. Hamilton, P. Lebon, B. Heron, L. Vallee, L. Quintana-Murci, A. Hovnanian, F. Rozenberg, E. Vivier, F. Geissmann, M. Tardieu, L. Abel, and J.L. Casanova TLR3 deficiency in patients with Herpes simplex encephalitis Science 317 2007 1522 1527 (Pubitemid 47417427)
70. Z. Zhang, B. Yuan, M. Bao, N. Lu, T. Kim, and Y.-J. Liu The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells Nat. Immunol. 12 2011 959 965